Biggest changeConsolidated EBITDA and Adjusted EBITDA from continuing operations are as follows: Year Ended December 31, ($ in thousands) 2024 2023 Consolidated Net loss from continuing operations $ (11,225) $ (34,151) Adjustments: Interest expense 418 4,238 Income taxes 6,159 (6,924) Depreciation 5,936 6,161 Amortization 1,487 1,505 EBITDA 2,775 (29,171) Acquisition costs and other 692 856 Goodwill impairment — 11,389 Gain on lease modification (67) — Stock-based compensation 204 594 Non-cash lease expense 198 242 Retention expense 3 26 Restructuring and severance costs 208 130 Adjusted EBITDA $ 4,013 $ (15,934) % sales 2.3 % (8.2) % 17 Table of Contents Specialty Chemicals EBITDA and Adjusted EBITDA are as follows: Year Ended December 31, ($ in thousands) 2024 2023 Specialty Chemicals Net income (loss) $ 1,093 $ (12,619) Adjustments: Interest expense 75 74 Depreciation 3,809 3,798 Amortization 695 634 EBITDA 5,672 (8,113) Acquisition costs and other 477 12 Goodwill impairment — 11,389 Stock-based compensation 7 8 Non-cash lease expense 66 88 Restructuring and severance costs 110 40 Specialty Chemicals Adjusted EBITDA $ 6,332 $ 3,424 % of segment sales 7.8 % 4.1 % Tubular Products EBITDA and Adjusted EBITDA from continuing operations are as follows: Year Ended December 31, ($ in thousands) 2024 2023 Tubular Products Net income (loss) from continuing operations $ 2,649 $ (11,210) Adjustments: Interest expense 1 — Depreciation 2,052 2,274 Amortization 792 871 EBITDA 5,494 (8,065) Acquisition costs and other 30 — Stock-based compensation 10 58 Non-cash lease expense 88 118 Retention expense — 8 Restructuring and severance costs 30 84 Tubular Products Adjusted EBITDA $ 5,652 $ (7,797) % of segment sales 5.8 % (7.1) % 18 Table of Contents Liquidity and Capital Resources We closely manage our liquidity and capital resources.
Biggest changeConsolidated EBITDA and Adjusted EBITDA from continuing operations are as follows: Year Ended December 31, ($ in thousands) 2025 2024 Consolidated Net loss from continuing operations $ (5,584) $ (12,577) Adjustments: Interest (income) expense, net (712) 417 Income taxes 22 1,806 Depreciation 3,576 3,884 Amortization 611 695 EBITDA (2,087) (5,775) Acquisition costs and other 731 662 Asset impairments 1,622 — Gain on lease modification (2,278) (67) Stock-based compensation 1,070 193 Non-cash lease expense 128 112 Retention expense — 3 Restructuring and severance costs 243 177 Adjusted EBITDA $ (571) $ (4,695) % sales (0.8) % (5.8) % 19 Table of Contents Specialty Chemicals EBITDA and Adjusted EBITDA are as follows: Year Ended December 31, ($ in thousands) 2025 2024 Specialty Chemicals Net income $ 3,700 $ 1,093 Adjustments: Interest expense 52 75 Depreciation 3,481 3,809 Amortization 611 695 EBITDA 7,844 5,672 Acquisition costs and other 93 477 Stock-based compensation 126 7 Non-cash lease expense 45 66 Restructuring and severance costs 14 110 Specialty Chemicals Adjusted EBITDA $ 8,122 $ 6,332 % of segment sales 10.8 % 7.8 % Liquidity and Capital Resources We closely manage our liquidity and capital resources.
The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. 22 Table of Contents We recognize net tax benefits under the recognition and measurement criteria of FASB ASC Topic 740, Income Taxes, which prescribes requirements and other guidance for financial statement recognition and measurement of positions taken or expected to be taken on tax returns.
The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. 23 Table of Contents We recognize net tax benefits under the recognition and measurement criteria of FASB ASC Topic 740, Income Taxes, which prescribes requirements and other guidance for financial statement recognition and measurement of positions taken or expected to be taken on tax returns.
Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations This discussion and analysis summarizes the significant factors affecting our consolidated operating results, financial condition, liquidity, and capital resources during the fiscal years ended December 31, 2024 and 2023.
Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations This discussion and analysis summarizes the significant factors affecting our consolidated operating results, financial condition, liquidity, and capital resources during the fiscal years ended December 31, 2025 and 2024.
Our existing cash, cash equivalents, and credit facilities balances may fluctuate during 2025. Cash from operations could also be affected by various risks and uncertainties detailed in Item 1A - Risk Factors of this report.
Our existing cash, cash equivalents, and credit facilities balances may fluctuate during 2026. Cash from operations could also be affected by various risks and uncertainties detailed in Item 1A - Risk Factors of this report.
Non-GAAP measures have limitations as analytical tools, and investors should not consider them in isolation or as a substitute for analysis of the Company's results or financial condition as reported under GAAP. 16 Table of Contents EBITDA and Adjusted EBITDA We define "EBITDA" as earnings before interest, income taxes, depreciation and amortization.
Non-GAAP measures have limitations as analytical tools, and investors should not consider them in isolation or as a substitute for analysis of the Company's results or financial condition as reported under GAAP. EBITDA and Adjusted EBITDA We define "EBITDA" as earnings before interest, income taxes, depreciation and amortization.
Our inventory reserve for estimated shrinkage was $0.3 million as of December 31, 2024. Judgments and uncertainties involved in the estimate We do not believe that our inventories are subject to significant risk of obsolescence in the near term and we have the ability to adjust purchasing practices based on anticipated sales trends and general economic conditions.
Our inventory reserve for estimated shrinkage was $0.1 million as of December 31, 2025. Judgments and uncertainties involved in the estimate We do not believe that our inventories are subject to significant risk of obsolescence in the near term and we have the ability to adjust purchasing practices based on anticipated sales trends and general economic conditions.
Non-GAAP measures should not be considered as an alternative to any measure of performance or financial condition as promulgated under GAAP, and investors should consider the Company's performance and financial condition as reported under GAAP and all other relevant information when assessing the performance or financial condition of the Company.
Non-GAAP measures should not be considered as 18 Table of Contents an alternative to any measure of performance or financial condition as promulgated under GAAP, and investors should consider the Company's performance and financial condition as reported under GAAP and all other relevant information when assessing the performance or financial condition of the Company.
Inventory Description Inventory is stated at the lower of cost or net realizable value. Cost is determined by either specific identification or weighted average methods. At the end of each quarter, all facilities review recent sales reports to identify sales price trends that would indicate products or product lines that are being sold below our cost.
Inventory Description Inventory is stated at the lower of cost or net realizable value. Cost is determined by either specific identification or weighted average methods. At the end of each quarter, recent sales reports are reviewed to identify sales price trends that would indicate products or product lines that are being sold below our cost.
However, it is possible that actual results could differ from recorded reserves. For instance, a 10% change in the amount of products considered obsolete would have decreased net earnings by $0.6 million for 2024. A 10% change in the estimated shrinkage rate would not have had a material impact on net earnings for 2024.
However, it is possible that actual results could differ from recorded reserves. For instance, a 10% change in the amount of products considered obsolete would have decreased net earnings by $0.1 million for 2025. A 10% change in the estimated shrinkage rate would not have had a material impact on net earnings for 2025.
As of December 31, 2024, the Company had no principal payments outstanding on long-term debt. As of December 31, 2024, the Company had $47.4 million of remaining availability under its credit facility. See Note 6 in the notes to the consolidated financial statements for additional information on the Company's line of credit.
As of December 31, 2025, the Company had no principal payments outstanding on long-term debt. As of December 31, 2025, the Company had $11.4 million of remaining availability under its credit facility. See Note 6 in the notes to the consolidated financial statements for additional information on the Company's line of credit.
Unless otherwise noted, all references herein for the years 2024 and 2023 represent the fiscal years ended December 31, 2024 and 2023, respectively.
Unless otherwise noted, all references herein for the years 2025 and 2024 represent the fiscal years ended December 31, 2025 and 2024, respectively.
The Company's effective tax rate for 2024 was less than the U.S. statutory rate of 21% primarily due to discrete tax charges associated with recording a valuation allowance on cumulative US Federal and state deferred tax assets.
The Company's effective tax rate for 2024 was less than the U.S. statutory rate of 21% primarily driven by discrete tax charges associated with recording a valuation allowance on cumulative US Federal and state deferred tax assets.
On February 17, 2025, the Board of Directors authorized a new share repurchase program allowing for repurchase of up to 1.0 million shares of the Company's outstanding common stock over 24 months. The shares will be purchased from time to time at prevailing market prices, through open market or privately negotiated transactions, depending on market conditions.
On December 19, 2025, the Board of Directors authorized a new share repurchase program allowing for repurchase of up to 2.0 million shares of the Company's outstanding common stock over 24 months. The shares will be purchased from time to time at prevailing market prices, through open market or privately negotiated transactions, depending on market conditions.
Results of these additional financial measures are as follows: Year ended December 31, 2024 2023 Current ratio 3.8 3.7 Return on average equity (11.3)% (38.6)% Material Cash Requirements from Contractual and Other Obligations As of December 31, 2024, our material cash requirements for our known contractual and other obligations were as follows: • Operating and Finance Leases - The Company enters into various lease agreements for real estate and manufacturing equipment used in the normal course of business.
Results of these additional financial measures are as follows: Year ended December 31, 2025 2024 Current ratio 6.7 2.8 Return on average equity (8.7)% (25.5)% Material Cash Requirements from Contractual and Other Obligations As of December 31, 2025, our material cash requirements for our known contractual and other obligations were as follows: • Operating and Finance Leases - The Company enters into various lease agreements for real estate and manufacturing equipment used in the normal course of business.
In 2024 and 2023, no dividends were declared or paid by the Company. 20 Table of Contents Other Financial Measures Below are additional financial measures that we believe are important in understanding the Company's liquidity position from year to year. The metrics are defined as: Liquidity Measure: • Current ratio = current asset divided by current liabilities.
In 2025 and 2024, no dividends were declared or paid by the Company. Other Financial Measures Below are additional financial measures that we believe are important in understanding the Company's liquidity position from year to year. The metrics are defined as: Liquidity Measure: • Current ratio = current asset divided by current liabilities.
We have provided valuation allowances as of December 31, 2024, aggregating to $9.1 million, net of federal benefit, against our federal deferred tax assets as well as certain state and local net operating loss carryforwards and other deferred tax assets. As of December 31, 2024, the Company has no liability for unrecognized income tax benefits.
We have provided valuation allowances as of December 31, 2025, aggregating to $8.4 million, net of federal benefit, against our federal deferred tax assets as well as certain state and local net operating loss carryforwards and other deferred tax assets. As of December 31, 2025, the Company has no liability for unrecognized income tax benefits.
The Facility contains covenants requiring the maintenance of a minimum consolidated fixed charge coverage ratio if excess availability falls below the greater of (i) $6.0 million and (ii) 15% of the revolving credit facility (currently $9.0 million). As of December 31, 2024, the Company was in compliance with all financial debt covenants.
The Facility contains covenants requiring the maintenance of a minimum consolidated fixed charge coverage ratio if excess availability falls below the greater of (i) $4.5 million and (ii) 15% of the revolving credit facility. As of December 31, 2025, the Company was in compliance with all financial debt covenants.
For those inventory items, a reserve is established for a percentage of the inventory cost less any estimated scrap proceeds and is based on our current knowledge with respect to inventory levels, sales trends and historical experience. During 2024, our reserve decreased approximately $0.1 million to $5.5 million as of December 31, 2024.
For those inventory items, a reserve is established for a percentage of the inventory cost and is based on our current knowledge with respect to inventory levels, sales trends and historical experience. During 2025, our reserve decreased approximately $0.1 million to $1.0 million as of December 31, 2025.
Operating and finance lease obligations were $32.9 million, with $1.8 million payable within 12 months. See Note 7 for further detail of our lease obligations and the timing of expected future payments.
Operating and finance lease obligations were $13.3 million, with $1.0 million payable within 12 months. See Note 7 for further detail of our lease obligations and the timing of expected future payments.
The Specialty Chemicals segment produces critical ingredients and process aids for the oil & gas, household, industrial and institutional ("HII"), personal care, coatings, adhesives, sealants and elastomers (CASE), pulp and paper, textile, automotive, agricultural, water treatment, construction and other industries.
These facilities produce critical ingredients and process aids for the oil & gas, household, industrial and institutional ("HII"), personal care, coatings, adhesives, sealants and elastomers ("CASE"), pulp and paper, textile, automotive, agricultural, water treatment, construction and other industries.
Sources of Liquidity Funds generated by operating activities supplemented by our available cash and cash equivalents and our credit facilities are our most significant sources of liquidity. As of December 31, 2024, we held $16.1 million of cash and cash equivalents, as well as $47.4 million of remaining available capacity on our revolving line of credit.
Sources of Liquidity Funds generated by operating activities supplemented by our available cash and cash equivalents and our credit facilities are our most significant sources of liquidity. As of December 31, 2025, we held $57.6 million of cash and cash equivalents, as well as $11.4 million of remaining available capacity on our revolving line of credit.
There is no guarantee as to the exact number of shares that will be repurchased by the Company, and the Company may discontinue purchases at any time that management determines additional purchases are not warranted. As of December 31, 2024, the Company had 435,608 shares of its previous share repurchase authorization remaining.
There is no guarantee as to the exact number of shares that will be repurchased by the Company, and the Company may discontinue 21 Table of Contents purchases at any time that management determines additional purchases are not warranted. As of December 31, 2025, the Company had 1,998,504 shares of its previous share repurchase authorization remaining.
We also record an inventory reserve for the estimated shrinkage (quantity losses) between physical inventories. This reserve is based upon the most recent physical inventory results. During 2024, the inventory shrink reserve had a $0.3 million decrease in response to estimated shrinkage rates based on results from previous physical inventories.
We also record an inventory reserve for the estimated shrinkage (quantity losses) between physical inventories. This reserve is based upon the most recent physical inventory results. During 2025, the inventory shrink reserve had an insignificant increase in response to estimated shrinkage rates based on results from previous physical inventories.
Inventory increased operating cash flows for the year ended December 31, 2024 by approximately $11.6 million compared to a decrease of approximately $12.2 million for 2023, while accounts payable decreased operating cash flows by approximately $3.6 million for the year ended December 31, 2024 compared to an increase of approximately $1.6 million for the year ended December 31, 2023.
Inventory decreased operating cash flows for the year ended December 31, 2025 by approximately $3.0 million compared to an increase of approximately $5.0 million for 2024, while accounts payable decreased operating cash flows by approximately $1.6 million 20 Table of Contents for the year ended December 31, 2025 compared to a decrease of approximately $3.2 million for the year ended December 31, 2024.
Short-term Debt The Company has a note payable in the amount of $0.9 million with an annual interest rate of 3.70% maturing April 1, 2024, associated with the financing of the Company's insurance premium in the current year. As of December 31, 2024, the outstanding balance was $0.4 million.
Short-term Debt The Company has a note payable in the amount of $1.1 million with an annual interest rate of 3.68% maturing April 1, 2026, associated with the financing of the Company's insurance premium in the current year. As of December 31, 2025, the outstanding balance was $0.4 million. Credit Facilities On December 10, 2025, Ascent Industries Co.
The Company has no off-balance sheet arrangements that are reasonably likely to have a material current or future effect on the Company's financial position, revenues, results of operations, liquidity, or capital expenditures. We expect capital spending in fiscal 2025 to be as much as $7.6 million.
The Company has no off-balance sheet arrangements that are reasonably likely to have a material current or future effect on the Company's financial position, revenues, results of operations, liquidity, or capital expenditures.
The changes in SG&A expense were primarily driven by increases in corporate allocation, incentive bonus expense and professional fees, partially offset by decreases in salaries, wages and benefits and taxes and license fees. Operating income for the full-year 2024 totaled $1.2 million compared to an operating loss of $12.6 million for the full-year 2023.
The changes in SG&A expense were primarily driven by increases in corporate allocation expense and incentive bonus expense, partially offset by decreases in salaries, wages and benefits, bad debt expense, professional fees and travel expense. Operating income for the full-year 2025 totaled $3.8 million compared to $1.2 million for the full-year 2024.
The increase in operating cash flows from inventory is primarily due to lower average inventory and higher inventory turns year over year while the decrease in accounts payable is primarily driven by a decreases in days payables outstanding within our Specialty Chemicals segment.
The decrease in operating cash flows from inventory is primarily due to lower inventory turns year over year partially offset by lower average inventory while the decrease in accounts payable is primarily driven by lower average accounts payable partially offset by decreases in days payables outstanding.
Critical Accounting Policies and Estimates The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.
We expect capital spending in fiscal 2026 to be as much as $5.5 million. 22 Table of Contents Critical Accounting Policies and Estimates The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.
The decrease in cash used in investing activities for the full-year 2024 compared to cash used in investing activities for the full-year 2023 was primarily driven by a decrease in capital expenditures in the current year over the prior year. Financing Activities Net cash used in financing activities primarily consist of transactions related to our long-term debt.
Investing Activities Net cash used in investing activities primarily consists of transactions related to capital expenditures. The increase in cash used in investing activities for the full-year 2025 compared to cash used in investing activities for the full-year 2024 was primarily driven by an increase in capital expenditures in the current year over the prior year.
This discussion and analysis is presented in five sections: • Executive Overview • Results of Operations and Non-GAAP Financial Measures • Liquidity and Capital Resources • Material Cash Requirements from Contractual and Other Obligations • Critical Accounting Policies and Estimates Executive Overview Ascent Industries Co. is a diverse industrials company focused on the production of specialty chemicals and stainless steel pipe and tube.
This discussion and analysis is presented in five sections: • Executive Overview • Results of Operations and Non-GAAP Financial Measures • Liquidity and Capital Resources • Material Cash Requirements from Contractual and Other Obligations • Critical Accounting Policies and Estimates Executive Overview Ascent Industries Co. is a specialty chemicals platform focused on the development, production, and distribution of tailored, performance-driven chemical solutions with three production facilities located in Cleveland, Tennessee, Fountain Inn, South Carolina and Danville, Virginia.
Cash Flows Cash flows from continuing operations were as follows: Year ended December 31, (in thousands) 2024 2023 Total cash provided by (used in): Operating activities 17,007 6,644 Investing activities (1,892) (2,885) Financing activities (1,329) (73,169) Net increase (decrease) in cash and cash equivalents $ 13,786 $ (69,410) Operating Activities The increase in cash provided by operating activities for the year ended December 31, 2024 compared to cash used in operating activities in the year ended December 31, 2023 was primarily driven by changes in working capital.
Cash Flows Cash flows from continuing operations were as follows: Year ended December 31, (in thousands) 2025 2024 Net cash (used in) provided by: Operating activities (7,269) 977 Investing activities (1,544) (1,120) Financing activities (8,945) (1,318) Net decrease in cash and cash equivalents $ (17,758) $ (1,461) Operating Activities The increase in cash used in operating activities for the year ended December 31, 2025 compared to cash provided by operating activities in the year ended December 31, 2024 was primarily driven by changes in working capital.
Accounts receivable increased operating cash flow by approximately $2.8 million compared to an increase of $6.8 million driven by lower sales in the current year partially offset by lower days sales outstanding.
Accounts receivable and advances decreased operating cash flow by approximately $2.6 million compared to an increase of $2.8 million in 2024. The decrease is primarily driven by the $5.3 million of escrow receivables from the BRISMET and ASTI divestitures in the current year partially offset by decreases in days sales outstanding.
The decrease in net sales was primarily driven by an 8.8% decrease in average selling prices coupled with a 0.9% decrease in pounds shipped. Full-year 2024 gross profit from continuing operations increased 1349.1% to $22.1 million, or 12.4% of sales, compared to $1.5 million, or 0.8% of sales, in the full-year 2023.
The decrease in net sales was primarily driven by a 17.7% decrease in pounds shipped partially offset by a 10.9% increase in average selling prices . Full-year 2025 gross profit from continuing operations increased 61.0% to $17.2 million, or 23.0% of sales, compared to $10.7 million, or 13.2% of sales, in the full-year 2024.
The decrease in net sales was primarily driven by a 16.8% decrease in average selling prices offset by a 5.5% increase in pounds shipped. SG&A expense increased $1.2 million, or 16.0%, for the full-year 2024 when compared to 2023. SG&A as a percentage of sales was 9.0% of sales for 2024 and 6.9% of sales for 2023.
The decrease in net sales was primarily driven by a 17.7% decrease in pounds shipped partially offset by a 10.9% decrease in average selling prices. SG&A expense increased by $3.8 million, or 40.0%, to $13.4 million in 2025 compared to $9.5 million in 2024. SG&A as a percentage of sales increased to 17.8% in 2025 from 11.8% in 2024.
Shares repurchased for the year ended December 31, 2024 and 2023 were as follows: Year ended December 31, 2024 2023 Number of shares repurchased 101,263 143,108 Average price per share $ 10.21 $ 8.97 Total cost of shares repurchased $ 1,037,346 $ 1,287,416 At the end of each fiscal year, the Board reviews the financial performance and capital needed to support future growth to determine the amount of cash dividend, if any, which is appropriate.
Shares repurchased for the year ended December 31, 2025 and 2024 were as follows: Year ended December 31, 2025 2024 Share repurchase program 1 740,683 101,263 Shares withheld from employees 4,841 — Total shares repurchased 745,524 101,263 Average price per share $ 12.26 $ 10.21 Total cost of shares repurchased 2 $ 9,159,661 $ 1,037,346 1 Includes 745 shares repurchased under previous share repurchase program which expired on February 17, 2025 and 743,283 shares repurchased under the repurchase program authorized on February 17, 2025 2 Includes broker fees incurred as part of repurchase transactions At the end of each fiscal year, the Board reviews the financial performance and capital needed to support future growth to determine the amount of cash dividend, if any, which is appropriate.
Reference should be made to Note 13 to the consolidated financial statements included in Item 8 of this Form 10-K. 2024 2023 (in thousands) Amount % Amount % Net sales $ 80,764 100.0 % $ 83,616 100.0 % Cost of goods sold 69,574 86.1 % 77,807 93.1 % Gross profit 11,190 13.9 % 5,809 6.9 % Selling, general and administrative expense 9,546 11.8 % 6,966 8.3 % Acquisition costs and other 477 0.6 % 12 — % Goodwill impairment — — % 11,389 13.6 % Operating income (loss) $ 1,167 1.4 % $ (12,558) (15.0) % Table of Contents Comparison of 2024 to 2023 - Tubular Products Net sales for the Tubular Products segment totaled $97.1 million for the full year of 2024, a decrease of 11.3% compared to the full-year 2023.
Reference should be made to Note 13 to the consolidated financial statements included in Item 8 of this Form 10-K. 2025 2024 (in thousands) Amount % Amount % Net sales $ 74,942 100.0 % $ 80,763 100.0 % Cost of goods sold 57,730 77.0 % 69,574 86.1 % Gross profit 17,212 23.0 % 11,189 13.9 % Selling, general and administrative expense 13,369 17.8 % 9,546 11.8 % Acquisition costs and other 92 0.1 % 477 0.6 % Operating income $ 3,751 5.0 % $ 1,166 1.5 % Net sales for the Specialty Chemicals segment decreased 7.2%, or $5.8 million, to $74.9 million for 2025 compared to $80.8 million in 2024.
The decrease was driven by lower debt outstanding in the current year compared to the prior year. The Company had no debt outstanding as of December 31, 2024.
Interest income was $0.8 million for 2025 compared to interest expense of $0.3 million in 2024 The change was driven by a higher interest-bearing cash balance in the current year compared to the prior year. The Company had no debt outstanding as of December 31, 2025.
Long-term Debt On November 6, 2024, Ascent entered into a Limited Consent, Third Amendment to Credit Agreement to Loan Documents with BMO Bank N.A. under Ascent’s credit facility (the “Credit Facility Amendment”).
(“Ascent”) entered into a Limited Waiver, Consent and Sixth Amendment to Credit Agreement and Omnibus Amendment to Loan Documents with BMO Bank N.A. and the other lenders under Ascent’s credit facility (the “Sixth Credit Facility Amendment”).
The increase in operating income was primarily driven by improved strategic sourcing initiatives and product line management resulting in lower raw material costs. The following tables summarize operating results for the two years indicated.
The increase in operating income was primarily driven by increases in gross profit as a result of improved strategic sourcing initiatives and product line management resulting in lower raw material costs as well as operational cost management and efficiencies and lower SG&A costs.
The increase in dollars and percentage of sales for the full-year 2024 were primarily driven by improved strategic sourcing initiatives and product line management resulting in lower raw material costs. Selling, general and administrative expense (SG&A) from continuing operations for the full-year 2024 decreased $0.1 million to $26.6 million compared to $26.7 million for the full-year 2023.
The increase in dollars and percentage of sales for the full-year 2025 were primarily driven by improved strategic sourcing initiatives and product line management resulting in lower raw material costs as well as operational cost management and efficiencies.
On December 22, 2023, the Company and its wholly-owned subsidiary Specialty Pipe & Tube, Inc. (“SPT”) entered into an Asset Purchase Agreement pursuant to which Ascent and SPT sold substantially all of the assets primarily related to SPT to Specialty Pipe & Tube Operations, LLC, a Delaware limited liability company.
("BRISMET"), entered into an Asset Purchase Agreement (the “Purchase Agreement”) pursuant to which they sold substantially all of the assets related to BRISMET to Bristol Pipe and Tube, Inc., a Delaware corporation and wholly-owned subsidiary of Ta Chen International, Inc. (the “Purchaser”).
The Credit Facility Amendment also increased the interest rate for the credit facility from SOFR plus an interest rate margin of between 1.85% and 2.10% to SOFR plus an interest rate margin of between 1.85% and 2.35%, depending on average availability under the credit facility and Ascent’s consolidated fixed charge coverage ratio.
The maximum revolving loan commitment under the credit facility remains $30 million with an interest rate between 1.85% and 2.35%, depending on average availability under the credit facility and the Company's consolidated fixed charge coverage ratio. The term of the credit facility remains through December 31, 2027.
The changes in SG&A expense were primarily driven by: • decreases in salaries, wages and benefits driven by lower headcount in the current year; • decreases in taxes and licenses; and, • decreases in other expenses primarily driven by decreases in share-based compensation expense The full-year decreases were partially offset by: • increases in incentive bonus driven by higher attainment of performance goals in the current year over the prior year; • increases in professional fees driven by increased IT and legal expenses in the current year Operating loss from continuing operations for the full-year 2024 improved to $5.1 million compared to an operating loss of $37.4 million for the full-year 2023.
The changes in SG&A expense were primarily driven by: • strategic investments in salaries, wages and benefits resulting in higher headcount in the current year; • increases in rent expense, specifically related to the reclass of remaining Munhall rent expense to SG&A from COGS in the current year; and, • increases in other expenses primarily driven by increases in share-based compensation expense, incentive bonus, taxes and licenses and dues and subscription fees.
The changes in SG&A expense were primarily driven by increases in corporate allocation partially offset by decreases in salaries, wages and benefits, taxes and license fees and professional fees. Operating income for the full-year 2024 totaled $2.6 million compared to an operating loss of $11.2 million for the full-year 2023.
The full-year decrease results are primarily driven by increases in corporate allocation expense to operating locations and decreases in professional fees partially offset by increases in salaries, wages and benefits, stock compensation, incentive bonus, dues and subscriptions and rent expense.
The Company's effective tax rate for 2023 was less than the U.S. statutory rate of 21% primarily driven by tax benefits associated with non-deductible goodwill impairment.
The Company's effective tax rate for 2025 was less than the U.S. statutory rate of 21% primarily driven by state taxes, net of federal benefit, adjustments to the valuation allowance in the period and increases in stock-based compensation.
The operating income increase for the full-year 2024 was primarily driven by increases in gross profit partially offset by the aforementioned increases in SG&A expenses. The following table summarizes operating results for the two years indicated.
Operating loss from continuing operations for the full-year 2025 improved to $7.0 million compared to an operating loss of $10.8 million for the full-year 2024. The operating loss decrease for the full-year 2025 was primarily driven by aforementioned increase in gross profit and non-cash lease modification gains partially offset by increases in SG&A expense and asset impairment expense.
SG&A expense increased by $2.6 million, or 37.0%, to $9.5 million in 2024 compared to $7.0 million in 2023. SG&A as a percentage of sales increased to 11.8% in 2024 from 8.3% in 2023.
Selling, general and administrative expense (SG&A) from continuing operations for the full-year 2025 increased $3.2 million to $24.1 million compared to $20.9 million for the full-year 2024. SG&A as a percentage of sales was 32.1% of sales for 2025 and 25.9% of sales for 2024.
Ascent Industries Co. was incorporated in 1958 as the successor to a chemical manufacturing business founded in 1945 known as Blackman Uhler Industries Inc.
End users include companies that use our products as raw materials or process aids in the manufacturing of products such as cleaners, coatings, water treatment chemicals, metal working fluids, textiles, oilfield production chemicals, agrochemical formulations and other applications The Company was incorporated in 1958 as the successor to a chemical manufacturing business founded in 1945 known as Blackman Uhler Industries, Inc.